The 17th World Congress on Controversies in Neurology pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Two studies report few complications from continuing ocrelizumab and natalizumab into pregnancy, with high live birth rates, a decline in elective abortions, and few major congenital abnormalities in newborns.
#ECTRIMS2022 – Study Examines Ocrevus Use and Pregnancy | Multiple Sclerosis News Today multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.
New data on COVID vaccination in MS patients has shown a reduced humoral response in patients treated with certain medications including ocrelizumab, rituximab, and fingolimod but not others.